Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
- 3rd side (hint)
respiration
|
process by which gasses are exchanged
|
|
|
ventilation
|
process of moving air into & out of lungs
|
|
|
inspiration
|
movement of air into lungs
|
|
|
expiration
|
movement of air out of lungs
|
|
|
pharynx
|
passageway for food from mouth > esophagus & for air from nost > larynx
|
|
|
trachea
|
passageway for air from pharynx > bronchi
|
|
|
bronchi
|
primary passageway of the bronchial tree that contains smooth muscle
|
|
|
alveoli
|
dilated sacs at end of bronchial tree where gas exchange occurs
|
|
|
perfusion
|
blood flow through a tissue or organ
|
|
|
bronchodilation
|
increase in diameter or airway due to relaxation of bronchial smooth muscle
|
|
|
bronchoconstriction
|
decrease in diameter of airway due to contraction of bronchial smooth muscle
|
|
|
bronchospasm
|
rapid constriction of airways
|
|
|
nebulizers
|
used to convert liquid drugs into fine mist to be inhaled
|
|
|
dry powder inhaler (DPI)
|
used to convert solid drug to fine powder to be inhaled
|
|
|
metered dose inhaler (MDI)
|
used to deliver a precise amount of drug to respiratory system
|
|
|
asthma
|
chronic inflammatory disease of airways
S/S: acute bronchospasm - dyspnea - coughing - gasping for air - mucous secretion - edema of airways |
|
|
dyspnea
|
shortness of breath
|
|
|
status asthmaticus
|
acute form of asthma requiring immediate medical attention
|
|
|
antitussive
|
drug used to suppress cough
|
|
|
chronic bronchitis
|
chronic disease of lungs characterized by excess mucous production & inflammation
|
|
|
emphysema
|
terminal lung disease characterized by dilation of alveoli
|
|
|
expectorant
|
drug used to increase bronchial secretions
|
|
|
mucolytic
|
drug used to loosen thick mucous
|
|
|
salmeterol
|
AKA: Serevent
CLASS: bronchodilator ACTION: selectively binding to beta2-adrenergic receptors in bronchiolar smooth muscle A/E: headaches - nervousness - restlessness - tachycardia |
bronchdilator
|
|
beclomethasone
|
AKA: Beclovent - Vanceril
CLASS: glucocorticoid ACTION: reduces inflammation & decreases asthma attacks - NOT bronchodilator A/E: voice hoarseness - can mask infections - Candidiasis (fungal infection) |
glucocorticoid
|
|
The primary use of glucocorticoids such as beclomethasone (Beconase) in asthma is to terminate acute asthmatic attacks.
TRUE or FALSE |
FALSE
Inhaled glucocorticoids are used for the long-term prevention of asthmatic attacks. p383 |
|
|
Activation of the sympathetic nervous system results in bronchoconstriction.
TRUE or FALSE |
FALSE
During periods of rest, nerves from the parasympathetic nervous system are activated, causing the bronchiolar smooth muscle to contract and the lumen to narrow, resulting in bronchoconstriction. p379 |
|
|
Which of the following classes would LEAST likely be prescribed for asthma?
a. beta2-agonists b. methylxanthines c. glucocorticoids d. beta-blockers |
d. beta-blockers
|
|
|
Which of the following classes are theMOST effective drugs for relieving acute bronchospasm?
a. beta2-agonists b. mast cell stabilizers c. methylxanthines d. anticholinergics |
a. beta2-agonists
|
|
|
Salmeterol (Serevent) is NOT indicated for the termination of acute bronchospasm because it:
a. is not absorbed orally b. takes too long to act c. affects only beta1-receptors d. causes too much CNS stimulation |
b. takes too long to act
|
|
|
For the prophylaxis of non-persistent asthma, glucocorticoids are most commonly administered by which route?
a. oral b. topical c. intranasal d. intradermal |
c. intranasal
|
|
|
Long-term treatment with oral glucocorticoids may cause which serious adverse effect?
a. rebound congestion b. hypertension c. cancer d. adrenal atrophy |
d. adrenal atrophy
|
|
|
Candidiasis of the throat is a common complication during therapy with which class of medications?
a. inhaled glucocorticoids b. mast cell stabilizers c. beta2-agonists d. mucolytics |
a. inhaled glucocorticoids
|
|
|
The primary use of mast cell inhibitors in the treatment of asthma is to:
a. terminate acute asthmatic attacks b. prevent asthmatic attacks c. reduce secretions d. reduce infections |
b. prevent asthmatic attacks
|
|
|
Nedocromil (Tilade) and cromolyn act by:
a. causing bronchodilation b. suppressing the cough reflex c. blocking histamine release d. drying bronchial secretions |
c. blocking histamine release
|
|